AltheaDx Prospective, Randomized Controlled Clinical Trial Demonstrates Significant Improvements in the Treatment of Depression and Anxiety over Standard of Care
SAN DIEGO, Sept. 26, 2017 /PRNewswire/ — AltheaDx, Inc. (“AltheaDx” or the “Company”), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, announced today that the results from its clinical trial have been accepted for publication… Read the rest “AltheaDx Prospective, Randomized Controlled Clinical Trial Demonstrates Significant Improvements in the Treatment of Depression and Anxiety over Standard of Care”